The Urologic Oncology Program at Rutgers Cancer Institute and Robert Wood Johnson University Hospital offers blue light cystoscopy with Cysview® (hexaminolevulinate hydrochloride) to help improve detection of certain bladder cancers. Cysview is an optical imaging agent that makes non-muscle invasive bladder cancer glow bright pink in blue light, enabling urologists to better see and remove tumors with greater accuracy.

Based at Princeton University, the Ludwig Princeton Branch is wholly dedicated to the study of cancer metabolism. Combined with Ludwig’s leadership in cancer epigenetics and immunotherapy, advances in cancer metabolism generated at the Ludwig Princeton Branch inform new strategies for cancer prevention and treatment.